
|Articles|May 27, 2004
AUA: Post-marketing studies of ED therapies are under review
The latest update of AUA guidelines for management of organic erectile dysfunction will focus on novel treatment recommendations and suggestions for study designs that minimize conflicts of interest in post-marketing comparisons of oral drug therapies.
Advertisement
Newsletter
Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
The UroOnc Minute: Adjuvant Therapy in Renal Cell Carcinoma, with Brian Shuch, MD
2
FDA approves sildenafil oral film for men with erectile dysfunction
3
Pearls & Perspectives: Modern Semen Testing and Male Fertility Care, with Thomas Masterson, MD
4
Head-to-head analysis shows OS benefit with apalutamide vs darolutamide in mCSPC
5






